Cryo-EM Workflows Guide Drug Discovery for Intractable Targets
Broadcast Date: November 11, 2021Time: 9:00 am PT, 12:00 am ET, 18:00 CET
REGISTER NOW
Ion channels are important clinical targets that play a central role in cellular...
Take the Hassle Out of Nanoparticle Prep and Characterization with Big Tuna and Stunner
This GEN webinar, sponsored by Unchained Labs, will show that whether a nanoparticle’s payload is RNA, DNA, protein, or another API, Big Tuna handles buffer exchange and concentration while Stunner delivers dye-free, label-free, standard-free, hassle-free quant.
CAR-T Connect: Explore, Discover, Exchange
From R&D through Process Development to Manufacturing, our CAR-T Connect virtual event offers a unique opportunity to interact with CAR-T therapy pioneers from start-ups to big pharma. This virtual event, sponsored by Sartorius, includes access to expert plenary presentations, lively Q&A and discussions, networking opportunities, and focused break-out sessions.
Predicting Heart Failure Using the Plasma Proteome
In this GEN webinar, sponsored by SomaLogic, our distinguished speaker, Dr. David Lanfear, will explore a new large-scale protein array, SomaScan, using an established heart failure (HF) patient registry to understand how the plasma proteome could meaningfully predict the risk of death or HF worsening and add to best conventional risk stratification, including clinical score and natriuretic peptides.
Analytical Solutions for Cell & Gene Therapy
In TODAY's GEN webinar, sponsored by Waters, our presenters will describe some of the latest analytical methods to determine LNP composition and impurity profiles using LC-MS and LC-ELSD (evaporative light scattering detector) devices. Additionally, we will also learn how LC-MS can be effectively used to determine mRNA 5' capping efficiency.
Advances in CNS Drug Discovery: Focus on Neurodegenerative Diseases
In this GEN webinar, sponsored by WuXi AppTec, our expert panel will focus on novel approaches for developing therapeutics in the field of neurodegenerative disorders. Throughout these talks, we will explore examples of novel in vitro, in vivo, and ex vivo models and technologies that are currently advancing modern CNS drug discovery
Cell Therapy Manufacturing and Clinical Comparability: What, How, and When
In this GEN webinar, our expert panelists will share insights on establishing a robust, automated cell manufacturing process that meets clinical and commercial demands while successfully navigating the ever-changing regulatory landscape for establishing comparability in a clinical product.
Addressing the Challenges of Scaling Cell Therapies
In this GEN webinar, sponsored by Charles River, Dr. Matthew Hewitt and Dr. Kimberly Negrin—experts in the field of human-derived biological products and manufacturing—will explore these distinct challenges and strategies to mitigate them. From the sheer volume of donors necessary to support cell therapy programs and the benefit of dedicated donor pools—to current testing and manufacturing gaps and the emerging solutions and processes that can increase quality, consistency, and efficiency.
Combatting SARS-CoV-2 Variants: Neutralization Testing from Alpha to Mu
Join this GEN webinar, sponsored by Integral Molecular, to learn how SARS-CoV-2 Reporter Virus Particles (RVPs, pseudotyped viruses) enable researchers to rapidly test neutralization titers of antibodies and vaccinee sera in a safe BSL-2 environment.
